Brainstem Gipr -expressing cells have been implicated in suppressing nausea-related behaviours, such as conditioned taste avoidance (CTA), as long-acting GIPR agonists reduced CTA triggered by PYY(3-36), GLP-1 or GDF15 administration 13,14,15,18,19
Around the two-week mark, most patients begin to notice physical changes in the abdominal area
The main sources of inconsistency in the NOS scale were sample representativeness and sample size
IV infusion therapy is not suitable for you if you are pregnant, breastfeeding, or if you have cardiovascular disease, high blood pressure, diabetes, liver or kidney diseases
Here is the critical caveat
When treatment is discontinued, appetite returns, metabolic rate adjustments reverse, and weight regain begins